Skip to main content
. 2015 Oct 7;106(11):1625–1634. doi: 10.1111/cas.12770

Table 5.

Univariate and multivariate analyses of the association between overall survival and prognostic factors in 180 patients with non‐small‐cell lung cancer

Variable HR (95%CI) P‐value
Univariate
Age 1.01 (0.97–1.04) 0.017*
Gender (male vs female) 2.51 (1.32–5.27) 0.004*
Smoking status (Brinkman index ≥400) 1.71 (0.99–3.08) 0.052
Pathologic stage (I vs II–IV) 2.27 (1.72–3.00) <0.001*
T factor (T1/T2/T3/T4) 2.65 (1.98–3.53) <0.001*
N factor (N0/N1/N2) 2.01 (1.46–2.75) <0.001*
M factor (M0/M1) 3.68 (1.11–9.01) 0.035*
Vessel invasion (positive vs negative) 2.49 (1.45–4.38) <0.001*
Lymphatic invasion (positive vs negative) 4.90 (2.63–10.0) <0.001*
Pleural invasion (positive vs negative) 3.91 (2.30–6.80) <0.001*
Type of surgery (lobar vs sublobar) 2.44 (1.07–7.03) 0.031*
Psf3 (positive vs negative) 2.13 (1.24–3.79) 0.006*
Multivariate
Age 1.04 (1.01–1.08) 0.003*
Gender (male vs female) 2.30 (1.17–4.99) 0.014*
Pathologic stage (I vs II–IV) 1.02 (0.46–2.19) 0.951
T factor (T1/T2/T3/T4) 2.58 (1.54–4.41) <0.001*
N factor (N0/N1/N2) 1.57 (0.82–3.07) 0.174
M factor (M0/M1) 1.14 (0.24–6.33) 0.871
Vessel invasion (positive vs negative) 1.19 (0.43–1.65) 0.604
Lymphatic invasion (positive vs negative) 2.52 (1.15–5.91) 0.021*
Pleural invasion (positive vs negative) 1.36 (0.69–2.72) 0.369
Type of surgery (lobar vs sublobar) 1.53 (0.47–4.35) 0.456
Psf3 (positive vs negative) 1.76 (1.01–3.22) 0.049*

CI, confidence interval; HR, hazard ratio. *Statistically significant.